三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
国内在研的IGF-1R靶点药物临床进度总结
国内在研的IGF-1R靶点药物临床进度总结
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:64KB
图片尺寸:2080*487
同报告图片
/
4
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
所属报告:
信达生物-港股公司研究报告-非肿瘤领域即将迎来重磅商业化产品-250313(37页).pdf
打包全文图表
相关数据
IGF-1R靶点药物国内竞争格局(仅统计临床进展达到I期及以上)
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
收藏
竞争格局
2025-04-29
原图定位
查看详情
IBI311(替妥尤单抗,IGF-1R)RESTORE-1三期研究结果
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
收藏
行业数据
2025-03-14
原图定位
查看详情
IBI311(替妥尤单抗,IGF-1R)作用机理
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
收藏
行业数据
2025-03-14
原图定位
查看详情
IGF-1R靶点药物国内竞争格局(I期及以上)
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
收藏
竞争格局
2024-10-21
原图定位
查看详情
SY707除ALK外针对靶点IGF1R、PTK2B、FAK更差异化
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
收藏
行业数据
2023-05-19
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
目前,国内在研的 IGF-1R 靶点药物中,信达生物的 IBI311 进度领先,2024 年 5 月,公司已向NMPA递交上市申请,其他三家在研产品主要来自上海泽纳仕生物、苏州普乐康,以及明慧医药,目前均处于临床 I 期或 II 期阶段。
行业数据
原图定位
当前图表所属:
信达生物-港股公司研究报告-非肿瘤领域即将迎来重磅商业化产品-250313(37页).pdf
2024WCLCIBI363治疗非小细胞肺癌临床I期
全球PD-1/IL-2在研药物临床试验总结
NMPA批准上市的PD-1单抗
信达生物肿瘤在研管线总结
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》